HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott K Kuwada Selected Research

Exanthema (Rash)

3/2016Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott K Kuwada Research Topics

Disease

11Neoplasms (Cancer)
10/2020 - 01/2004
5Colonic Neoplasms (Colon Cancer)
04/2012 - 12/2002
4Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 05/2005
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2018 - 01/2004
3Adenoma (Adenomas)
01/2018 - 10/2008
2Polyps
01/2018 - 03/2016
2Neoplasm Metastasis (Metastasis)
02/2015 - 12/2002
2Pancreatic Neoplasms (Pancreatic Cancer)
04/2012 - 03/2012
2Peritoneal Neoplasms
04/2012 - 03/2012
2Renal Cell Carcinoma (Grawitz Tumor)
09/2011 - 02/2007
1Non-alcoholic Fatty Liver Disease
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Liver Diseases (Liver Disease)
01/2020
1Acne Vulgaris
03/2016
1Exanthema (Rash)
03/2016
1Liver Neoplasms (Liver Cancer)
07/2013
1Ovarian Neoplasms (Ovarian Cancer)
03/2012
1Intestinal Polyps
09/2011
1Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal)
09/2011
1Adenomatous Polyps
10/2008
1Macular Degeneration (Age-Related Maculopathy)
02/2007
1Hyperplasia
11/2006
1Necrosis
03/2004

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
06/2012 - 01/2004
2SaltsIBA
01/2018 - 03/2016
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 03/2016
2Sulindac (Copal)FDA LinkGeneric
01/2018 - 03/2016
2Biological ProductsIBA
02/2015 - 03/2012
2Phosphotransferases (Kinase)IBA
06/2012 - 09/2007
2BAY 11-7085IBA
04/2012 - 03/2012
2LigandsIBA
04/2012 - 03/2004
2ErbB Receptors (EGF Receptor)IBA
09/2007 - 03/2004
2Tyrosine (L-Tyrosine)FDA Link
09/2007 - 03/2004
1MicroRNAs (MicroRNA)IBA
10/2020
1Pioglitazone (Actos)FDA Link
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Vitamin EFDA LinkGeneric
01/2020
1AcrylonitrileIBA
02/2015
1Histones (Histone)IBA
06/2012
1Transcription Factors (Transcription Factor)IBA
06/2012
1ChromatinIBA
06/2012
1Protein Isoforms (Isoforms)IBA
06/2012
1macroH2A histoneIBA
06/2012
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
04/2012
1Death Domain ReceptorsIBA
04/2012
1MTOR InhibitorsIBA
09/2011
1EverolimusFDA Link
09/2011
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
09/2011
1Caspase 3 (Caspase-3)IBA
07/2009
1AlkaloidsIBA
07/2009
1naamidine AIBA
07/2009
1Antineoplastic Agents (Antineoplastics)IBA
07/2009
1Calcibiotic Root Canal SealerIBA
10/2008
1Monoclonal AntibodiesIBA
09/2007
1Cetuximab (Erbitux)FDA Link
09/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2007
1Bevacizumab (Avastin)FDA Link
09/2007
1Integrin beta1IBA
02/2007
1volociximabIBA
02/2007
1IntegrinsIBA
11/2006
1Integrin alpha5IBA
05/2005
1Trastuzumab (Herceptin)FDA Link
03/2004
1AntibodiesIBA
03/2004
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2004
1NF-kappa B (NF-kB)IBA
12/2002

Therapy/Procedure

3Therapeutics
01/2020 - 03/2004
2Chemoprevention
03/2016 - 09/2011
1Restorative Proctocolectomy
01/2018
1Liver Transplantation
07/2013
1Adjuvant Chemotherapy
09/2007